NUVB · CUSIP 67080N101
NUVATION BIO INC
Reported by 2 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-08-24.
- Managers holding
- 2
- Average portfolio weight
- 0.1%
- Combined reported value
- $7.4M
- Research group
- 79
2 of the 79 superinvestors Shameless Cloning tracks reported NUVATION BIO INC (NUVB) in their Q2 2026 13F filings, worth $7.4M combined, at an average 0.1% of their portfolios. The largest positions by portfolio weight belong to David Abrams (0.1%), David Einhorn (0.0%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| David AbramsABRAMS CAPITAL MANAGEMENT, L.P. | 0.1% | $7.2M |
| David EinhornDME Capital Management, LP | 0.0% | $199K |